Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
UBS
US Army
Citi
McKinsey
Federal Trade Commission
Cerilliant
Chinese Patent Office
Colorcon

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,061,703

« Back to Dashboard

Summary for Patent: 5,061,703
Title: Adamantane derivatives in the prevention and treatment of cerebral ischemia
Abstract:A method for the prevention and treatment of cerebral ischemia using an adamantane derivative of the formula ##STR1## wherein R.sub.1 and R.sub.2 are identical or different, representing hydrogen or a straight or branched alkyl group of 1 to 6 C atoms or, in conjunction with N, a heterocyclic group with 5 or 6 ring C atoms; wherein R.sub.3 and R.sub.4 are identical or different, being selected from hydrogen, a straight or branched alkyl group of 1 to 6 C atoms, a cycloalkyl group with 5 or 6 C atoms, and phenyl; wherein R.sub.5 is hydrogen or a straight or branched C.sub.1 -C.sub.6 alkyl group, or a pharmaceutically-acceptable salt thereof, is disclosed.
Inventor(s): Bormann; Joachim (Frankfurt, DE), Gold; Markus R. (Nauheim, DE), Schatton; Wolfgang (Eschborn, DE)
Assignee: Merz + Co. GmbH & Co. (Frankfurt am Main, DE)
Application Number:07/508,109
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,061,703

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,061,703

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
89106657Apr 14, 1989

International Patents Family Members for US Patent 5,061,703

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 94384 ➤ Subscribe
Canada 2014453 ➤ Subscribe
Switzerland 679208 ➤ Subscribe
German Democratic Republic 293493 ➤ Subscribe
Germany 10299048 ➤ Subscribe
Germany 58905637 ➤ Subscribe
Denmark 173356 ➤ Subscribe
Denmark 91690 ➤ Subscribe
European Patent Office 0392059 ➤ Subscribe 90988 Luxembourg ➤ Subscribe
European Patent Office 0392059 ➤ Subscribe SPC/GB02/046 United Kingdom ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Daiichi Sankyo
Express Scripts
Farmers Insurance
Julphar
Deloitte
Citi
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot